Prelude Capital Management’s Cyclerion Therapeutics CYCN Stock Holding History

Prelude Capital Management’s Portfolio CYCN Stock Details CYCN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$80K	Sell
2022 Q2	$69K	Buy
2022 Q1	$111K	Buy
2021 Q4	$133K	Buy
2021 Q3	$131K	Sell
2021 Q2	$195K	Buy
2019 Q4	–	Sell
2019 Q3	$12K	Buy